Calyxt to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

Calyxt, a plant-based synthetic biology company (Nasdaq: CLXT), announced that its CEO Michael A. Carr and CFO Bill Koschak will present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022. Their presentation is scheduled for September 13 at 2:30 p.m. ET, and a webcast is available here. Attendees can also arrange 1:1 meetings. More details and the presentation replay can be found on Calyxt's website.

ROSEVILLE, Minn., Sept. 7, 2022 /PRNewswire/ -- Calyxt, Inc. (Nasdaq: CLXT), a plant-based synthetic biology company, today announced that Michael A. Carr, President and Chief Executive Officer, and Bill Koschak, Chief Financial Officer, will present at the H.C Wainwright 24^th Annual Global Investment Conference taking place September 12-14, 2022.

H.C. Wainwright 24^th Annual Global Investment Conference
Date: Tuesday, September 13, 2022
Time: 2:30 p.m. ET
Webcast: https://journey.ct.events/view/89f76b34-90f0-4836-b94b-90b001e47b2a

Management is also available for 1:1 meetings during the conference. Conference attendees should reach out to the event organizers or investors@calyxt.com to schedule.

The presentation will be available for viewing and replay from the Investors section of Calyxt's website at www.calyxt.com.

About Calyxt:

Calyxt (Nasdaq: CLXT) is a plant-based synthetic biology company. The Company leverages its proprietary PlantSpring™ technology platform to engineer plant metabolism to produce innovative high value plant-based chemistries for use in customers' materials and products. As plant-based solutions, the Company's synthetic biology products can be used in helping customers meet their sustainability targets and financial goals. Calyxt's diversified offerings are primarily delivered through its proprietary BioFactory™ production system. For more information, visit www.calyxt.com.

PlantSpring, BioFactory, Plant Cell Matrix™, and the Calyxt logo are trademarks of Calyxt, Inc. Any other trademarks belong to their respective owners.

Contacts:

Calyxt Media Contact:	Calyxt Investor Relations Contact:
Brennan Burks Calyxt, Inc. (651) 724-5788 brennan.burks@calyxt.com	Kimberly Minarovich/ Cameron Willis Argot Partners (212) 600-1902 investors@calyxt.com

 

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/calyxt-to-present-at-the-hc-wainwright-24th-annual-global-investment-conference-301618955.html

SOURCE Calyxt, Inc.

FAQ

When and where is Calyxt presenting at the H.C. Wainwright conference?

Calyxt will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 13, 2022, at 2:30 p.m. ET.

Who from Calyxt is presenting at the H.C. Wainwright conference?

Michael A. Carr, the CEO, and Bill Koschak, the CFO, will present for Calyxt at the conference.

How can I access Calyxt's presentation from the conference?

The presentation will be available for viewing and replay on Calyxt's website.

What is the significance of Calyxt's participation in the conference?

Calyxt's participation allows them to highlight their innovative plant-based synthetic biology solutions to potential investors.

Can I schedule a 1:1 meeting with Calyxt's management during the conference?

Yes, attendees can reach out to the event organizers or email investors@calyxt.com to schedule 1:1 meetings.